Literature DB >> 29284372

Histologic Grade Does Not Predict Outcome in Dogs with Appendicular Osteosarcoma Receiving the Standard of Care.

Courtney R Schott1, Laetitia J Tatiersky1, Robert A Foster1, Geoffrey A Wood1.   

Abstract

Canine appendicular osteosarcoma is an aggressive bone neoplasm that imposes a short survival time. There are several published histologic grading systems for canine osteosarcoma but no universally accepted system. Location within the skeleton and therapy received are both correlated with survival time, but these factors were not always considered when the prognostic value of published grading systems was determined. Our objective was to compare 2 published histologic grading systems in a population of dogs with appendicular osteosarcoma treated with the standard of care for curative intent. Three evaluators graded 85 tumors using 2 histologic grading systems. The relationships between histologic grade as well as individual histologic features and outcome (survival time and disease-free interval) were evaluated using Kaplan-Meier survival functions and a univariate Cox proportional hazards model. Histologic grade, as assigned by any evaluator, did not correlate with outcome. Increased number of mitotic figures per 3 randomly selected 400× microscope fields, as assessed by 1 evaluator, was correlated with both survival time and disease-free interval; this was the only individual histologic feature that was significantly correlated with outcome for any evaluator. These findings cast doubt on the predictive value of routine histologic grading in dogs with appendicular osteosarcoma who receive amputation followed by adjuvant chemotherapy and highlight the need for better tools to predict outcome in canine appendicular osteosarcoma.

Entities:  

Keywords:  anatomic site; asymmetry; biopsy; bone; disease-free survival; dogs; grading; histology; neoplasia; osteosarcoma; prognosis

Mesh:

Year:  2017        PMID: 29284372     DOI: 10.1177/0300985817747329

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  11 in total

Review 1.  Canine and murine models of osteosarcoma.

Authors:  Jessica Beck; Ling Ren; Shan Huang; Erika Berger; Kathleen Bardales; Joshua Mannheimer; Christina Mazcko; Amy LeBlanc
Journal:  Vet Pathol       Date:  2022-03-26       Impact factor: 3.157

2.  Prospective clinical trial testing COXEN-based gene expression models of chemosensitivity in dogs with spontaneous osteosarcoma.

Authors:  Daniel L Gustafson; Keagan P Collins; Jared S Fowles; E J Ehrhart; Kristen M Weishaar; Sunetra Das; Dawn L Duval; Douglas H Thamm
Journal:  Cancer Chemother Pharmacol       Date:  2021-07-14       Impact factor: 3.333

3.  An evaluation of TAZ and YAP crosstalk with TGFβ signalling in canine osteosarcoma suggests involvement of hippo signalling in disease progression.

Authors:  Anita K Luu; Courtney R Schott; Robert Jones; Andrew C Poon; Brandon Golding; Roa'a Hamed; Benjamin Deheshi; Anthony Mutsaers; Geoffrey A Wood; Alicia M Viloria-Petit
Journal:  BMC Vet Res       Date:  2018-11-26       Impact factor: 2.741

4.  Prognostic value of fluorine18 flourodeoxyglucose positron emission tomography/computed tomography in dogs with appendicular osteosarcoma.

Authors:  Lynn R Griffin; Douglas H Thamm; Ariel Brody; Laura E Selmic
Journal:  J Vet Intern Med       Date:  2019-02-15       Impact factor: 3.333

5.  Parathyroid hormone receptor 1 (PTHR1) is a prognostic indicator in canine osteosarcoma.

Authors:  Awf A Al-Khan; Judith S Nimmo; Mourad Tayebi; Stewart D Ryan; James O Simcock; Raboola Tarzi; Charles A Kuntz; Eman S Saad; Michael J Day; Samantha J Richardson; Janine A Danks
Journal:  Sci Rep       Date:  2020-01-31       Impact factor: 4.379

Review 6.  Targeting Mechanotransduction in Osteosarcoma: A Comparative Oncology Perspective.

Authors:  Anita K Luu; Alicia M Viloria-Petit
Journal:  Int J Mol Sci       Date:  2020-10-14       Impact factor: 5.923

7.  Dog breeds and body conformations with predisposition to osteosarcoma in the UK: a case-control study.

Authors:  Sam Beck; Rachel J Errington; Sara Gould; Helen Winter; Grace L Edmunds; Matthew J Smalley; Dave C Brodbelt; Dan G O'Neill
Journal:  Canine Med Genet       Date:  2021-03-10

8.  MicroRNA Expression Changes and Integrated Pathways Associated With Poor Outcome in Canine Osteosarcoma.

Authors:  Deanna D Dailey; Ann M Hess; Gerrit J Bouma; Dawn L Duval
Journal:  Front Vet Sci       Date:  2021-04-15

9.  Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine.

Authors:  Cecilia Gola; Diana Giannuzzi; Andrea Rinaldi; Selina Iussich; Paola Modesto; Emanuela Morello; Paolo Buracco; Luca Aresu; Raffaella De Maria
Journal:  Front Vet Sci       Date:  2021-05-17

10.  Prognostic significance of circulating microRNA-214 and -126 in dogs with appendicular osteosarcoma receiving amputation and chemotherapy.

Authors:  Kazuki Heishima; Travis Meuten; Kyoko Yoshida; Takashi Mori; Douglas H Thamm
Journal:  BMC Vet Res       Date:  2019-01-25       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.